Kazia Therapeutics Statistics
Total Valuation
KZIA has a market cap or net worth of $151.98 million. The enterprise value is $106.17 million.
| Market Cap | 151.98M |
| Enterprise Value | 106.17M |
Important Dates
The last earnings date was Monday, March 30, 2026, before market open.
| Earnings Date | Mar 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KZIA has 11.43 million shares outstanding. The number of shares has increased by 213.01% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 11.43M |
| Shares Change (YoY) | +213.01% |
| Shares Change (QoQ) | +132.62% |
| Owned by Insiders (%) | 18.61% |
| Owned by Institutions (%) | 16.85% |
| Float | 8.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 120.37 |
| Forward PS | 1,465.72 |
| PB Ratio | 4.88 |
| P/TBV Ratio | 5.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 83.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.87, with a Debt / Equity ratio of 0.00.
| Current Ratio | 2.87 |
| Quick Ratio | 2.86 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -106.90% and return on invested capital (ROIC) is -53.34%.
| Return on Equity (ROE) | -106.90% |
| Return on Assets (ROA) | -25.70% |
| Return on Invested Capital (ROIC) | -53.34% |
| Return on Capital Employed (ROCE) | -39.17% |
| Weighted Average Cost of Capital (WACC) | 16.08% |
| Revenue Per Employee | $211,072 |
| Profits Per Employee | -$2.53M |
| Employee Count | 6 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.07M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +30.91% in the last 52 weeks. The beta is 2.15, so KZIA's price volatility has been higher than the market average.
| Beta (5Y) | 2.15 |
| 52-Week Price Change | +30.91% |
| 50-Day Moving Average | 13.18 |
| 200-Day Moving Average | 9.46 |
| Relative Strength Index (RSI) | 50.67 |
| Average Volume (20 Days) | 164,866 |
Short Selling Information
The latest short interest is 646,048, so 5.66% of the outstanding shares have been sold short.
| Short Interest | 646,048 |
| Short Previous Month | 631,195 |
| Short % of Shares Out | 5.66% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.56 |
Income Statement
In the last 12 months, KZIA had revenue of $1.27 million and -$15.21 million in losses. Loss per share was -$6.82.
| Revenue | 1.27M |
| Gross Profit | 1.27M |
| Operating Income | -12.21M |
| Pretax Income | -16.28M |
| Net Income | -15.21M |
| EBITDA | -11.90M |
| EBIT | -12.21M |
| Loss Per Share | -$6.82 |
Balance Sheet
The company has $46.33 million in cash and $65,906 in debt, with a net cash position of $46.27 million or $4.05 per share.
| Cash & Cash Equivalents | 46.33M |
| Total Debt | 65,906 |
| Net Cash | 46.27M |
| Net Cash Per Share | $4.05 |
| Equity (Book Value) | 30.99M |
| Book Value Per Share | 2.73 |
| Working Capital | 30.42M |
Cash Flow
| Operating Cash Flow | -9.60M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 326,332 |
| Net Borrowing | n/a |
| Free Cash Flow | -10.08M |
| FCF Per Share | -$0.88 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -964.22% |
| Pretax Margin | -1,285.72% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KZIA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -213.01% |
| Shareholder Yield | -213.01% |
| Earnings Yield | -9.98% |
| FCF Yield | -6.61% |
Analyst Forecast
The average price target for KZIA is $27.74, which is 108.57% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $27.74 |
| Price Target Difference | 108.57% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | -53.83% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 17, 2025. It was a reverse split with a ratio of 1:5.
| Last Split Date | Apr 17, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
KZIA has an Altman Z-Score of -2.53 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.53 |
| Piotroski F-Score | 2 |